(Q71645285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Bone remodelling in monoclonal gammopathies of uncertain significance, symptomatic and nonsymptomatic myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

M Laroche

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Attal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

C Dromer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 July 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

published in

Clinical Rheumatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

347-352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

Biologic, histologic and densitometric effects of oral risedronate on bone in patients with multiple myeloma

20 October 2019

cites work

1 reference

12 December 2020

Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group

1 reference

12 December 2020

Serum osteocalcin in the management of myeloma

1 reference

12 December 2020

Multiple-myeloma bone disease. The comparative effect of sodium fluoride and calcium carbonate or placebo

1 reference

12 December 2020

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

12 December 2020

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry

1 reference

12 December 2020

Ineffectiveness of Fluoride Therapy in Multiple Myeloma

1 reference

12 December 2020

Quantitative histology of myeloma-induced bone changes

1 reference

12 December 2020

[Contribution of bone biopsy with histomorphometry in the evaluation of monoclonal gammopathy]

1 reference

12 December 2020

Risk of disease progression in asymptomatic multiple myeloma

1 reference

12 December 2020

Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis

1 reference

12 December 2020

Physiological senile involution and pathological rarefaction of bone. Quantitative and comparative histological data

1 reference

12 December 2020

Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease

1 reference

12 December 2020

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

12 December 2020

Tetracycline-based histological analysis of bone remodeling

1 reference

12 December 2020

Mechanisms of bone lesions in multiple myeloma.

1 reference

12 December 2020

Abnormal serum bone Gla protein levels in multiple myeloma. Crucial role of bone formation and prognostic implications

1 reference

12 December 2020

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

1 reference

12 December 2020

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

1 reference

12 December 2020

Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy

1 reference

12 December 2020

Diagnostic procedures in disorders of calcium metabolism

1 reference

12 December 2020

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption

1 reference

12 December 2020

Evidence for the secretion of an osteoclast stimulating factor in myeloma.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02230356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8853167%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference